PUMA BIOTECHNOLOGY INC shareholders Q3 2023

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 71 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

PUMA BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$4,713,2604.15%
Eversept Partners, LP 1,681,149$4,421,4220.37%
Camber Capital Management LP 4,235,000$11,1380.37%
Kynam Capital Management, LP 473,975$1,246,5540.20%
GLOBEFLEX CAPITAL L P 538,559$1,416,4100.17%
Affinity Asset Advisors, LLC 202,349$532,1780.15%
GSA CAPITAL PARTNERS LLP 279,629$7350.06%
RICE HALL JAMES & ASSOCIATES, LLC 363,666$956,4420.06%
Patriot Financial Group Insurance Agency, LLC 67,000$176,2100.04%
ACADIAN ASSET MANAGEMENT LLC 1,858,000$4,8840.02%
Prospera Financial Services Inc 122,892$323,1840.01%
Crestline Management, LP 32,639$85,8410.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 148,400$390,2920.01%
Renaissance Technologies 1,726,602$4,5410.01%
XTX Topco Ltd 15,289$40,2100.01%
Hillsdale Investment Management Inc. 27,276$71,7350.01%
Virtu Financial LLC 14,262$380.00%
MILLENNIUM MANAGEMENT LLC 3,083,349$8,109,2080.00%
Connor, Clark & Lunn Investment Management Ltd. 199,767$525,3870.00%
Jump Financial, LLC 24,690$64,9350.00%
External links

This page lists PUMA BIOTECHNOLOGY INC's shareholders in Q3 2023. To view PUMA BIOTECHNOLOGY INC's shareholder history, click here.